Press coverage about Capnia (NASDAQ:SLNO) has trended somewhat positive on Sunday, Accern Sentiment reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Capnia earned a daily sentiment score of 0.17 on Accern’s scale. Accern also gave media stories about the company an impact score of 46.3654856028672 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
These are some of the headlines that may have impacted Accern’s scoring:
Shares of Capnia (NASDAQ:SLNO) traded up $0.17 on Friday, hitting $1.72. The stock had a trading volume of 4,644,185 shares, compared to its average volume of 37,650. Capnia has a 12 month low of $1.32 and a 12 month high of $6.60.
SLNO has been the subject of several research reports. Maxim Group set a $25.00 target price on Capnia and gave the company a “buy” rating in a research note on Thursday, October 12th. ValuEngine upgraded Capnia from a “strong sell” rating to a “sell” rating in a research note on Friday, October 6th. Finally, reduced their target price on Capnia from $25.00 to $8.00 and set a “buy” rating for the company in a research note on Wednesday, November 15th.
TRADEMARK VIOLATION WARNING: “Capnia (SLNO) Getting Somewhat Positive Media Coverage, Study Shows” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2017/12/10/capnia-slno-getting-somewhat-positive-media-coverage-study-shows-2.html.
Soleno Therapeutics, Inc, formerly Capnia, Inc, is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.
Receive News & Ratings for Capnia Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capnia Inc. and related companies with MarketBeat.com's FREE daily email newsletter.